Recently, when the mRNA expression of BACH2 was studied in untreated CLL patients with age-matched healthy donors, BACH2 mRNA expression was shown to be reduced in CD4+ T-cells, CD8+ T-cells, and leukemic B-cells [16]. This evidence concerns the gene BACH2 and B-cell chronic lymphocytic leukemia.